The Journal of Biochemistry · 1989 · 49 citations · 0 references
Life SciencesBiochemistryPharmacologyBiochemical PharmacologyMolecular PharmacologyStructure-activity RelationshipsEnzyme InhibitionVenom BiologyColumn ChromatographyEnzyme Mechanism-based InhibitionMechanism-based InhibitionMolecular Weight DeterminationPhospholipase A2 InhibitionPhospholipase A2 PathwayVenom Composition AnalysisVenom Pharmacology
Phospholipase A2 inhibitor was purified from the blood plasma of Habu, Trimeresurus flavoviridis, by Sephadex G-200 gel filtration, DEAE-cellulose chromatography, and Blue-Sepharose CL-6B column chromatography. The purified inhibitor was shown to be a glycoprotein with a molecular weight of about 100K. It was found to consist of four subunits whose molecular weights were around 20-24K. In order to examine the inhibition mechanism of the inhibitor, the interaction of the inhibitor with a phospholipase A2 from T. flavoviridis venom was examined by Sephadex G-100 gel filtration. One inhibitor molecule was found to bind directly to one phospholipase A2 molecule in both the presence and absence of Ca2+. The inhibitor inhibited the phospholipase A2 from T. flavoviridis venom with an apparent dissociation constant, Ki, of 1.7 X 10(-10) M, but not the porcine pancreas enzyme or the Agkistrodon halys blomhoffii enzyme belonging to the same family, Crotalidae, as T. flavoviridis, or the phospholipase C from Bacillus cereus.